Trial intelligence / Profile preview

PENG Block for Hip Arthroscopy

NCT04508504Completed

Sponsor
University of Virginia
Start
Dec 2020
Primary completion
Feb 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by University of Virginia. Primary endpoint: PACU Pain Score at 30 months. Started Dec 2020; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04508504.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04508504.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call